To further explore the clinical implications of TLR4, we find that the expression of TLR4 is significantly lower in elderly patients (age >65 years), high pathological grade tumor, higher tumor stage, and progressive tumor (Figures 2A–D,G). This evidence concerns the gene TLR4 and neoplasm.